HIV molecular immunology database

 

Search Antibody Database

Found 2 matching records:

Displaying record number 736

Download this epitope record as JSON.

MAb ID polyclonal
HXB2 Location Env Env Epitope Map
Author Location gp120
Epitope
Ab Type  
Neutralizing L P
Species (Isotype) human
Patient  
Immunogen vaccine
Keywords  

Vaccine Details

Vaccine type canarypox prime with gp120 boost
Vaccine strain B clade SF2
Vaccine component Env, Gag

Notes

Showing 1 of 1 note.

References

Showing 1 of 1 reference.

Belshe1998 R. B. Belshe, G. J. Gorse, M. Mulligan, T. Evans, M. Keefer, J. Excler, A. Duliege, J. Tartaglia, W. Cox, J. McNamara, K. Hwang, A. Bradney, D. Montifiori, K. Weinhold, and NIAID AIDS Vaccine Evaluation Group. Induction of immune responses to HIV-1 canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. AIDS, 12:2407-15, 1998. PubMed ID: 9875578. Show all entries for this paper.


Displaying record number 737

Download this epitope record as JSON.

MAb ID polyclonal
HXB2 Location Env Env Epitope Map
Author Location gp120
Epitope
Ab Type  
Neutralizing L
Species (Isotype) human
Patient  
Immunogen vaccine
Keywords  

Vaccine Details

Vaccine type canarypox prime with gp120 boost
Vaccine strain B clade LAI, B clade MN, B clade SF2
Vaccine component Gag, gp120, Protease
Adjuvant MF59

Notes

Showing 1 of 1 note.

References

Showing 2 of 2 reference.

Belshe1998 R. B. Belshe, G. J. Gorse, M. Mulligan, T. Evans, M. Keefer, J. Excler, A. Duliege, J. Tartaglia, W. Cox, J. McNamara, K. Hwang, A. Bradney, D. Montifiori, K. Weinhold, and NIAID AIDS Vaccine Evaluation Group. Induction of immune responses to HIV-1 canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. AIDS, 12:2407-15, 1998. PubMed ID: 9875578. Show all entries for this paper.

Belshe2001 Robert B. Belshe, Cladd Stevens, Geoffrey J. Gorse, Susan Buchbinder, Kent Weinhold, Haynes Sheppard, Donald Stablein, Steve Self, James McNamara, Sharon Frey, Jorge Flores, Jean Louis Excler, Michel Klein, Raphaelle El Habib, Anee-Marie Duliege, Clayton Harro, Lawrence Corey, Michael Keefer, Mark Mulligan, Peter Wright, Connie Celum, Frank Judson, Kenneth Mayer, David McKirnan, Micahel Marmor, and National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group and HIV Network for Prevention Trials (HIVNET). Safety and Immunogenicity of a Canarypox-Vectored Human Immunodeficiency Virus Type 1 Vaccine with or without gp120: A Phase 2 Study in Higher- and Lower-Risk Volunteers. J. Infect. Dis., 183(9):1343-1352, 1 May 2001. PubMed ID: 11294665. Show all entries for this paper.


Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health